Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chondrosarcoma-from Molecular Pathology to Novel Therapies
Agnieszka Zając, Sylwia Kopeć, Bartłomiej Szostakowski, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2390-2390
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Chondrosarcoma: A Clinical Review
Aaron Gazendam, Snežana Popović, Naveen Parasu, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 7, pp. 2506-2506
Open Access | Times Cited: 56
Recent Advances in the Treatment of Bone Metastases and Primary Bone Tumors: An Up-to-Date Review
Adrian Bădilă, Dragoș Mihai Rădulescu, Adelina-Gabriela Niculescu, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4229-4229
Open Access | Times Cited: 66
Iron oxide nanoparticles coated with bioactive materials: a viable theragnostic strategy to improve osteosarcoma treatment
Amy Sarah Benjamin, Sunita Nayak
Discover Nano (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Chondrosarcoma: New Molecular Insights, Challenges in Near-Patient Preclinical Modeling, and Therapeutic Approaches
Lorena Landuzzi, Francesca Ruzzi, Pier‐Luigi Lollini, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1542-1542
Open Access | Times Cited: 1
Primary Skull Base Chondrosarcomas: A Systematic Review
Paolo Palmisciano, Ali S. Haider, Mohammadmahdi Sabahi, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 5960-5960
Open Access | Times Cited: 44
Therapeutic Targets and Emerging Treatments in Advanced Chondrosarcoma
Shinji Miwa, Norio Yamamoto, Katsuhiro Hayashi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1096-1096
Open Access | Times Cited: 33
Vascular Anomaly Syndromes in the ISSVA Classification System: Imaging Findings and Role of Interventional Radiology in Management
Mindy X. Wang, Serageldin Kamel, Khaled M. Elsayes, et al.
Radiographics (2022) Vol. 42, Iss. 6, pp. 1598-1620
Closed Access | Times Cited: 28
Bone tumors effective therapy through functionalized hydrogels: current developments and future expectations
Ruyi Shao, Yeben Wang, Laifeng Li, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 1631-1647
Open Access | Times Cited: 27
Melatonin inhibits chondrosarcoma cell proliferation and metastasis by enhancing miR‐520f‐3p production and suppressing MMP7 expression
Nguyen Bao Tran, Chih‐Yang Lin, Ting‐Kuo Chang, et al.
Journal of Pineal Research (2023) Vol. 75, Iss. 1
Closed Access | Times Cited: 14
Single-cell RNA-seq reveals intratumoral heterogeneity in osteosarcoma patients: A review
Dylan D. Thomas, Ryan A. Lacinski, Brock A. Lindsey
Journal of bone oncology (2023) Vol. 39, pp. 100475-100475
Open Access | Times Cited: 12
Secondary peripheral chondrosarcoma in multiple osteochondromas: a retrospective single-institution case series
Maria Gnoli, Marco Gambarotti, Alberto Righi, et al.
Orphanet Journal of Rare Diseases (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 4
Emerging Treatments Targeting the Tumor Microenvironment for Advanced Chondrosarcoma
Vincenzo Ingangi, Annarosaria De Chiara, Gerardo Ferrara, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 977-977
Open Access | Times Cited: 4
A Multicomponent Training Program Improves Physical Function and Quality of Life for a Mesenchymal Chondrosarcoma Survivor Subjected to Internal Hemipelvectomy: A Case Study
Lucía Romero, Mar Cepero González, F. Javier Rojas
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1541-1541
Open Access
Advancements in Bone Malignancy Research through Next-Generation Sequencing Focussed on Osteosarcoma, Chondrosarcoma, and Ewing sarcoma
Naveen Jeyaraman, Madhan Jeyaraman, Pearl Subramanian, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155908-155908
Closed Access
Clinical Characteristics, Prognostic Factor and a Novel Dynamic Prediction Model for Overall Survival of Elderly Patients With Chondrosarcoma: A Population-Based Study
Yuexin Tong, Yuekai Cui, Liming Jiang, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 16
Mesenchymal Chondrosarcoma from Diagnosis to Clinical Trials
Monika Dudzisz‐Śledź, Monika Kondracka, Monika Rudzińska, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4581-4581
Open Access | Times Cited: 9
The ATR Inhibitor VE-821 Enhances the Radiosensitivity and Suppresses DNA Repair Mechanisms of Human Chondrosarcoma Cells
Birgit Lohberger, Dietmar Glänzer, Nicole Eck, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2315-2315
Open Access | Times Cited: 8
Shikonin derivatives cause apoptosis and cell cycle arrest in human chondrosarcoma cells via death receptors and MAPK regulation
Birgit Lohberger, Dietmar Glänzer, Heike Kaltenegger, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 11
A CT-based radiomics nomogram for predicting histologic grade and outcome in chondrosarcoma
Xiaoli Li, Xianglong Shi, Yanmei Wang, et al.
Cancer Imaging (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Proton-Based Radiation Therapy for Skull Base Chondrosarcomas in Children and Adolescents: 40-year experience from a single institution.
Myrsini Ioakeim‐Ioannidou, Saveli Goldberg, Tobias Urell, et al.
International Journal of Radiation Oncology*Biology*Physics (2024)
Closed Access | Times Cited: 2
Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical Trials
Weronika Zając, Julia Dróżdż, Weronika Kisielewska, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3924-3924
Open Access | Times Cited: 5
Chondrosarcoma of Sternal Origin: A Rare Case
Swaragandha S Jadhav, Avinash Dhok, Kajal Mitra, et al.
Cureus (2023)
Open Access | Times Cited: 4
Hydrogel-Based Drug Delivery Nanoparticles with Conventional Treatment Approaches for Cancer Tumors; A Comparative Study Using MCDM Technique
Dilber Uzun Ozsahin, Efe Precious Onakpojeruo, Berna Uzun
2022 Advances in Science and Engineering Technology International Conferences (ASET) (2023), pp. 1-9
Open Access | Times Cited: 4
Advancing the Management of Skull Base Chondrosarcomas: A Systematic Review of Targeted Therapies
Edoardo Agosti, Marco Zeppieri, Sara Antonietti, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 3, pp. 261-261
Open Access | Times Cited: 1
DNA-PKcs Inhibition Sensitizes Human Chondrosarcoma Cells to Carbon Ion Irradiation via Cell Cycle Arrest and Telomere Capping Disruption
Birgit Lohberger, Sandra Barna, Dietmar Glänzer, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6179-6179
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top